FDA Grants Emergency Authorisation to Cheap New COVID-19 Saliva Test – ScienceAlert

On Saturday, the US Food and Drug Administration granted emergency use authorization to a saliva-based test funded by the NBA and National Basketball Players Association to be available for public use, the agency announced.
The test was developed by researchers at Yale and jointly funded by the NBA and NBPA, ESPN reported.
Called “SalivaDirect”, the saliva-based test could be priced at an incredibly low rate.
Experts told ESPN that the cost per sample could be as low as US$4, but patients are…

Click here to view the original article.